Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring

ConclusionsThese results provide evidence that the enzalutamide/radiotherapy combination could maximize therapeutic responses in patients with enzalutamide-sensitive prostate cancer.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research